{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:24Z","timestamp":1792788504955,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Central Public-interest Scientific Institution Basal Research Fund","award":["1610302025002"],"award-info":[{"award-number":["1610302025002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Streptococcus suis<\/jats:italic>\n                    , an important zoonotic pathogen capable of transmission from pigs to humans, represents a critical threat to both public health and the global pork industry. The increasing prevalence of multidrug-resistant\u00a0\n                    <jats:italic>S. suis<\/jats:italic>\n                    \u00a0strains, coupled with their ability to form biofilms, has necessitated the development of alternative antimicrobial strategies. In this study, we characterized the therapeutic potential of Ply113, an endolysin derived from an\n                    <jats:italic>Enterococcus faecium<\/jats:italic>\n                    phage, against\n                    <jats:italic>S. suis<\/jats:italic>\n                    . Ply113 has shown potent bactericidal activity against\n                    <jats:italic>S. suis<\/jats:italic>\n                    in vitro, with rapid time-kill characteristics and broad-spectrum efficiency against clinically prevalent serotypes (2, 3, 4, 7, and 9). Transmission electron microscopy analysis revealed that Ply113 induced distinct morphological alterations in\n                    <jats:italic>S. suis<\/jats:italic>\n                    , including cell wall disintegration and cytoplasmic leakage. This endolysin exhibited anti-biofilm functionality, eradicating biofilms formed by clinical strain of\n                    <jats:italic>S. suis<\/jats:italic>\n                    in a concentration-dependent manner. In murine models of bacteremia, a single administration of Ply113 provided complete protection against lethal\n                    <jats:italic>S. suis<\/jats:italic>\n                    infection, significantly decreasing the bacterial burden in the liver and spleen and attenuating organ injury. Additionally, Ply113 has been shown to be safe for mice, with no adverse effects. Taken together, our findings indicate that Ply113 is a promising alternative antimicrobial agent for combating biofilm-related infections caused by\n                    <jats:italic>S. suis<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1186\/s13567-025-01608-7","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:55:20Z","timestamp":1756814120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Characterization of an enterococcal phage endolysin as a potential antimicrobial agent against Streptococcus suis"],"prefix":"10.1186","volume":"56","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuilong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2041-2208","authenticated-orcid":false,"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"1608_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2014.45","volume":"3","author":"G Goyette-Desjardins","year":"2014","unstructured":"Goyette-Desjardins G, Auger JP, Xu J, Segura M, Gottschalk M (2014) Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg Microbes Infect 3:e45","journal-title":"Emerg Microbes Infect"},{"key":"1608_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13028-020-00533-3","volume":"62","author":"A Werinder","year":"2020","unstructured":"Werinder A, Aspan A, Backhans A, Sjolund M, Guss B, Jacobson M (2020) Streptococcus suis in Swedish grower pigs: occurrence, serotypes, and antimicrobial susceptibility. Acta Vet Scand 62:36","journal-title":"Acta Vet Scand"},{"key":"1608_CR3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2460\/ajvr.79.9.941","volume":"79","author":"S Arai","year":"2018","unstructured":"Arai S, Kim H, Watanabe T, Tohya M, Suzuki E, Ishida-Kuroki K, Maruyama F, Murase K, Nakagawa I, Sekizaki T (2018) Assessment of pig saliva as a Streptococcus suis reservoir and potential source of infection on farms by use of a novel quantitative polymerase chain reaction assay. Am J Vet Res 79:941\u2013948","journal-title":"Am J Vet Res"},{"key":"1608_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2021.676002","volume":"8","author":"C Neila-Ibanez","year":"2021","unstructured":"Neila-Ibanez C, Casal J, Hennig-Pauka I, Stockhofe-Zurwieden N, Gottschalk M, Migura-Garcia L, Pailler-Garcia L, Napp S (2021) Stochastic assessment of the economic impact of Streptococcus suis-associated disease in German, Dutch and Spanish swine farms. Front Vet Sci 8:676002","journal-title":"Front Vet Sci"},{"key":"1608_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1086\/596763","volume":"48","author":"HF Wertheim","year":"2009","unstructured":"Wertheim HF, Nghia HD, Taylor W, Schultsz C (2009) Streptococcus suis: an emerging human pathogen. Clin Infect Dis 48:617\u2013625","journal-title":"Clin Infect Dis"},{"key":"1608_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.tim.2017.02.005","volume":"25","author":"M Segura","year":"2017","unstructured":"Segura M, Fittipaldi N, Calzas C, Gottschalk M (2017) Critical Streptococcus suis virulence factors: are they all really critical? Trends Microbiol 25:585\u2013599","journal-title":"Trends Microbiol"},{"key":"1608_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4161\/viru.28595","volume":"5","author":"Y Feng","year":"2014","unstructured":"Feng Y, Zhang H, Wu Z, Wang S, Cao M, Hu D, Wang C (2014) Streptococcus suis infection: an emerging\/reemerging challenge of bacterial infectious diseases? Virulence 5:477\u2013497","journal-title":"Virulence"},{"key":"1608_CR8","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3201\/eid1208.060232","volume":"12","author":"C Ye","year":"2006","unstructured":"Ye C, Zhu X, Jing H, Du H, Segura M, Zheng H, Kan B, Wang L, Bai X, Zhou Y, Cui Z, Zhang S, Jin D, Sun N, Luo X, Zhang J, Gong Z, Wang X, Wang L, Sun H, Li Z, Sun Q, Liu H, Dong B, Ke C, Yuan H, Wang H, Tian K, Wang Y, Gottschalk M, Xu J (2006) Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg Infect Dis 12:1203\u20131208","journal-title":"Emerg Infect Dis"},{"key":"1608_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1017\/S1466252307001247","volume":"8","author":"M Gottschalk","year":"2007","unstructured":"Gottschalk M, Segura M, Xu J (2007) Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim Health Res Rev 8:29\u201345","journal-title":"Anim Health Res Rev"},{"key":"1608_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9050374","volume":"9","author":"M Segura","year":"2020","unstructured":"Segura M, Aragon V, Brockmeier SL, Gebhart C, Greeff A, Kerdsin A, O\u2019Dea MA, Okura M, Salery M, Schultsz C, Valentin-Weigand P, Weinert LA, Wells JM, Gottschalk M (2020) Update on Streptococcus suis research and prevention in the era of antimicrobial restriction: 4th international workshop on S. suis. Pathogens 9:379","journal-title":"Pathogens"},{"key":"1608_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2217\/fmb.10.2","volume":"5","author":"M Gottschalk","year":"2010","unstructured":"Gottschalk M, Xu J, Calzas C, Segura M (2010) Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? Future Microbiol 5:371\u2013391","journal-title":"Future Microbiol"},{"key":"1608_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13567-022-01111-3","volume":"53","author":"C Uru\u00e9n","year":"2022","unstructured":"Uru\u00e9n C, Garc\u00eda C, Fraile L, Tommassen J, Arenas J (2022) How Streptococcus suis escapes antibiotic treatments. Vet Res 53:91","journal-title":"Vet Res"},{"key":"1608_CR13","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1586\/14760584.2015.1101349","volume":"14","author":"M Segura","year":"2015","unstructured":"Segura M (2015) Streptococcus suis vaccines: candidate antigens and progress. Expert Rev Vaccines 14:1587\u20131608","journal-title":"Expert Rev Vaccines"},{"key":"1608_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12866-016-0782-8","volume":"16","author":"TB Athey","year":"2016","unstructured":"Athey TB, Teatero S, Lacouture S, Takamatsu D, Gottschalk M, Fittipaldi N (2016) Determining Streptococcus suis serotype from short-read whole-genome sequencing data. BMC Microbiol 16:162","journal-title":"BMC Microbiol"},{"key":"1608_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/21597081.2015.1062590","volume":"5","author":"DR Roach","year":"2015","unstructured":"Roach DR, Donovan DM (2015) Antimicrobial bacteriophage-derived proteins and therapeutic applications. Bacteriophage 5:e1062590","journal-title":"Bacteriophage"},{"key":"1608_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/B978-0-12-394438-2.00007-4","volume":"83","author":"DC Nelson","year":"2012","unstructured":"Nelson DC, Schmelcher M, Rodriguez-Rubio L, Klumpp J, Pritchard DG, Dong S, Donovan DM (2012) Endolysins as antimicrobials. Adv Virus Res 83:299\u2013365","journal-title":"Adv Virus Res"},{"key":"1608_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.11.001","volume":"55","author":"VS Gondil","year":"2020","unstructured":"Gondil VS, Harjai K, Chhibber S (2020) Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections. Int J Antimicrob Agents 55:105844","journal-title":"Int J Antimicrob Agents"},{"key":"1608_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/v11020096","volume":"11","author":"K Abdelkader","year":"2019","unstructured":"Abdelkader K, Gerstmans H, Saafan A, Dishisha T, Briers Y (2019) The preclinical and clinical progress of bacteriophages and their lytic enzymes: the parts are easier than the whole. Viruses 11:96","journal-title":"Viruses"},{"key":"1608_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnw186","volume":"363","author":"H Zhang","year":"2016","unstructured":"Zhang H, Zhang C, Wang H, Yan YX, Sun J (2016) A novel prophage lysin Ply5218 with extended lytic activity and stability against Streptococcus suis infection. FEMS Microbiol Lett 363:fnw186","journal-title":"FEMS Microbiol Lett"},{"key":"1608_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054227","volume":"8","author":"F Tang","year":"2013","unstructured":"Tang F, Zhang W, Lu C (2013) Lysogenic Streptococcus suis isolate SS2-4 containing prophage SMP showed increased mortality in zebra fish compared to the wild-type isolate. PLoS One 8:e54227","journal-title":"PLoS One"},{"key":"1608_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2025.128147","volume":"296","author":"EK Osei","year":"2025","unstructured":"Osei EK, O\u2019Hea R, Cambillau C, Athalye A, Hille F, Franz C, O\u2019Doherty A, Wilson M, Murray GGR, Weinert LA, Manzanilla EG, Mahony J, Kenny JG (2025) Isolation of phages infecting the zoonotic pathogen Streptococcus suis reveals novel structural and genomic characteristics. Microbiol Res 296:128147","journal-title":"Microbiol Res"},{"key":"1608_CR22","doi-asserted-by":"publisher","first-page":"1304932","DOI":"10.3389\/fmicb.2023.1304932","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang J, Liang S, Lu X, Xu Q, Zhu Y, Yu S, Zhang W, Liu S, Xie F (2023) Bacteriophage endolysin Ply113 as a potent antibacterial agent against polymicrobial biofilms formed by enterococci and Staphylococcus aureus. Front Microbiol 14:1304932","journal-title":"Front Microbiol"},{"key":"1608_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072070","volume":"8","author":"Z Liu","year":"2013","unstructured":"Liu Z, Zheng H, Gottschalk M, Bai X, Lan R, Ji S, Liu H, Xu J (2013) Development of multiplex PCR assays for the identification of the 33 serotypes of Streptococcus suis. PLoS One 8:e72070","journal-title":"PLoS One"},{"key":"1608_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41522-023-00385-5","volume":"9","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhang X, Liang S, Wang J, Zhu Y, Zhang W, Liu S, Schwarz S, Xie F (2023) Bactericidal synergism between phage endolysin Ply2660 and cathelicidin LL-37 against vancomycin-resistant Enterococcus faecalis biofilms. NPJ Biofilms Microbiomes 9:16","journal-title":"NPJ Biofilms Microbiomes"},{"key":"1608_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106996","volume":"62","author":"S Gao","year":"2023","unstructured":"Gao S, Shen Y, Yuan S, Quan Y, Li X, Wang Y, Yi L, Wang Y (2023) Methyl anthranilate deteriorates biofilm structure of Streptococcus suis and antagonizes the capsular polysaccharide defence effect. Int J Antimicrob Agents 62:106996","journal-title":"Int J Antimicrob Agents"},{"key":"1608_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan4044","volume":"10","author":"A de Breij","year":"2018","unstructured":"de Breij A, Riool M, Cordfunke RA, Malanovic N, de Boer L, Koning RI, Ravensbergen E, Franken M, van der Heijde T, Boekema BK, Kwakman PHS, Kamp N, El Ghalbzouri A, Lohner K, Zaat SAJ, Drijfhout JW, Nibbering PH (2018) The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci Transl Med 10:eaan4044","journal-title":"Sci Transl Med"},{"key":"1608_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41522-024-00576-8","volume":"10","author":"M Li","year":"2024","unstructured":"Li M, Wang B, Chen J, Jiang L, Zhou Y, Guo G, Jiang F, Hu Y, Wang C, Yang Y, Tang J, Han P, Yu J, Shen H (2024) Staphylococcus aureus SaeRS impairs macrophage immune functions through bacterial clumps formation in the early stage of infection. NPJ Biofilms Microbiomes 10:102","journal-title":"NPJ Biofilms Microbiomes"},{"key":"1608_CR28","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1099\/00221287-146-10-2395","volume":"146","author":"A Heydorn","year":"2000","unstructured":"Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersboll BK, Molin S (2000) Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146:2395\u20132407","journal-title":"Microbiology"},{"key":"1608_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9:671\u2013675","journal-title":"Nat Methods"},{"key":"1608_CR30","doi-asserted-by":"publisher","first-page":"1403789","DOI":"10.3389\/fimmu.2024.1403789","volume":"15","author":"M Bleuze","year":"2024","unstructured":"Bleuze M, Lehoux M, Auger JP, Gottschalk M, Segura M (2024) The granulocyte colony-stimulating factor produced during Streptococcus suis infection controls neutrophil recruitment in the blood without affecting bacterial clearance. Front Immunol 15:1403789","journal-title":"Front Immunol"},{"key":"1608_CR31","doi-asserted-by":"publisher","first-page":"683","DOI":"10.26444\/aaem\/79813","volume":"24","author":"J Dutkiewicz","year":"2017","unstructured":"Dutkiewicz J, Sroka J, Zajac V, Wasinski B, Cisak E, Sawczyn A, Kloc A, Wojcik-Fatla A (2017) Streptococcus suis: a re-emerging pathogen associated with occupational exposure to pigs or pork products. Part I - epidemiology. Ann Agric Environ Med 24:683\u2013695","journal-title":"Ann Agric Environ Med"},{"key":"1608_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/aem.02160-24","volume":"91","author":"R Lv","year":"2025","unstructured":"Lv R, Zhang W, Sun Z, Si X, Dong H, Liu X (2025) Current prevalence and therapeutic strategies for porcine Streptococcus suis in China. Appl Environ Microbiol 91:e0216024","journal-title":"Appl Environ Microbiol"},{"key":"1608_CR33","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3390\/microorganisms9081765","volume":"9","author":"M Dechene-Tempier","year":"2021","unstructured":"Dechene-Tempier M, Marois-Crehan C, Libante V, Jouy E, Leblond-Bourget N, Payot S (2021) Update on the mechanisms of antibiotic resistance and the mobile resistome in the emerging zoonotic pathogen Streptococcus suis. Microorganisms 9:1765","journal-title":"Microorganisms"},{"key":"1608_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virol.2016.02.006","volume":"492","author":"P Gong","year":"2016","unstructured":"Gong P, Cheng M, Li X, Jiang H, Yu C, Kahaer N, Li J, Zhang L, Xia F, Hu L, Sun C, Feng X, Lei L, Han W, Gu J (2016) Characterization of Enterococcus faecium bacteriophage IME-EFm5 and its endolysin LysEFm5. Virology 492:11\u201320","journal-title":"Virology"},{"key":"1608_CR35","doi-asserted-by":"publisher","first-page":"10164","DOI":"10.1038\/s41598-017-10755-7","volume":"7","author":"M Cheng","year":"2017","unstructured":"Cheng M, Zhang Y, Li X, Liang J, Hu L, Gong P, Zhang L, Cai R, Zhang H, Ge J, Ji Y, Guo Z, Feng X, Sun C, Yang Y, Lei L, Han W, Gu J (2017) Endolysin LysEF-P10 shows potential as an alternative treatment strategy for multidrug-resistant Enterococcus faecalis infections. Sci Rep 7:10164","journal-title":"Sci Rep"},{"key":"1608_CR36","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1128\/AEM.01540-10","volume":"77","author":"J Uchiyama","year":"2011","unstructured":"Uchiyama J, Takemura I, Hayashi I, Matsuzaki S, Satoh M, Ujihara T, Murakami M, Imajoh M, Sugai M, Daibata M (2011) Characterization of lytic enzyme open reading frame 9 (ORF9) derived from Enterococcus faecalis bacteriophage phiEF24C. Appl Environ Microbiol 77:580\u2013585","journal-title":"Appl Environ Microbiol"},{"key":"1608_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2024.110005","volume":"290","author":"H Wang","year":"2024","unstructured":"Wang H, Fan Q, Wang Y, Yi L, Wang Y (2024) Rethinking the control of Streptococcus suis infection: biofilm formation. Vet Microbiol 290:110005","journal-title":"Vet Microbiol"},{"key":"1608_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00086","volume":"7","author":"F Ma","year":"2017","unstructured":"Ma F, Yi L, Yu N, Wang G, Ma Z, Lin H, Fan H (2017) Streptococcus suis serotype 2 biofilms inhibit the formation of neutrophil extracellular traps. Front Cell Infect Microbiol 7:86","journal-title":"Front Cell Infect Microbiol"},{"key":"1608_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02686-22","volume":"11","author":"L Yi","year":"2023","unstructured":"Yi L, Fan Q, Wang H, Fan H, Zuo J, Wang Y, Wang Y (2023) Establishment of Streptococcus suis biofilm infection model in vivo and comparative analysis of gene expression profiles between in vivo and in vitro biofilms. Microbiol Spectr 11:e0268622","journal-title":"Microbiol Spectr"},{"key":"1608_CR40","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1590\/S1517-83822012000300021","volume":"43","author":"G Dawei","year":"2012","unstructured":"Dawei G, Liping W, Chengping L (2012) In vitro biofilm forming potential of Streptococcus suis isolated from human and swine in China. Braz J Microbiol 43:993\u20131004","journal-title":"Braz J Microbiol"},{"key":"1608_CR41","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1007\/s00203-021-02438-9","volume":"203","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Chen R, Li M, Qi Z, Yu Y, Pan Z, Yao H, Feng Z, Zhang W (2021) The effectiveness of extended binding affinity of prophage lysin PlyARI against Streptococcus suis infection. Arch Microbiol 203:5163\u20135172","journal-title":"Arch Microbiol"},{"key":"1608_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2022.109425","volume":"268","author":"Z Wang","year":"2022","unstructured":"Wang Z, Liu X, Shi Z, Zhao R, Ji Y, Tang F, Guan Y, Feng X, Sun C, Lei L, Han W, Du XD, Gu J (2022) A novel lysin Ply1228 provides efficient protection against Streptococcus suis type 2 infection in a murine bacteremia model. Vet Microbiol 268:109425","journal-title":"Vet Microbiol"},{"key":"1608_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169180","volume":"12","author":"DB Gilmer","year":"2017","unstructured":"Gilmer DB, Schmitz JE, Thandar M, Euler CW, Fischetti VA (2017) The phage lysin PlySs2 decolonizes Streptococcus suis from murine intranasal mucosa. PLoS One 12:e0169180","journal-title":"PLoS One"},{"key":"1608_CR44","doi-asserted-by":"publisher","first-page":"7377","DOI":"10.1128\/AEM.02300-15","volume":"81","author":"F Tang","year":"2015","unstructured":"Tang F, Li D, Wang H, Ma Z, Lu C, Dai J (2015) Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections. Appl Environ Microbiol 81:7377\u20137384","journal-title":"Appl Environ Microbiol"},{"key":"1608_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnv205","volume":"362","author":"W Ji","year":"2015","unstructured":"Ji W, Huang Q, Sun L, Wang H, Yan Y, Sun J (2015) A novel endolysin disrupts Streptococcus suis with high efficiency. FEMS Microbiol Lett 362:fnv205","journal-title":"FEMS Microbiol Lett"},{"key":"1608_CR46","doi-asserted-by":"publisher","first-page":"8272","DOI":"10.1128\/AEM.05151-11","volume":"77","author":"X Meng","year":"2011","unstructured":"Meng X, Shi Y, Ji W, Meng X, Zhang J, Wang H, Lu C, Sun J, Yan Y (2011) Application of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen Streptococcus suis. Appl Environ Microbiol 77:8272\u20138279","journal-title":"Appl Environ Microbiol"},{"key":"1608_CR47","doi-asserted-by":"publisher","first-page":"16670","DOI":"10.3390\/ijms242316670","volume":"24","author":"H Xi","year":"2023","unstructured":"Xi H, Fu Y, Chen C, Feng X, Han W, Gu J, Ji Y (2023) Aerococcus viridans phage lysin AVPL had lytic activity against Streptococcus suis in a mouse bacteremia model. Int J Mol Sci 24:16670","journal-title":"Int J Mol Sci"},{"key":"1608_CR48","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/antibiotics10020124","volume":"10","author":"F Abdelrahman","year":"2021","unstructured":"Abdelrahman F, Easwaran M, Daramola OI, Ragab S, Lynch S, Oduselu TJ, Khan FM, Ayobami A, Adnan F, Torrents E, Sanmukh S, El-Shibiny A (2021) Phage-encoded endolysins. Antibiotics 10:124","journal-title":"Antibiotics"},{"key":"1608_CR49","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1128\/AAC.02232-13","volume":"58","author":"SY Jun","year":"2014","unstructured":"Jun SY, Jung GM, Yoon SJ, Choi YJ, Koh WS, Moon KS, Kang SH (2014) Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredient. Antimicrob Agents Chemother 58:2084\u20132088","journal-title":"Antimicrob Agents Chemother"},{"key":"1608_CR50","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/1440-1681.12613","volume":"43","author":"SY Jun","year":"2016","unstructured":"Jun SY, Jung GM, Yoon SJ, Youm SY, Han HY, Lee JH, Kang SH (2016) Pharmacokinetics of the phage endolysin-based candidate drug SAL200 in monkeys and its appropriate intravenous dosing period. Clin Exp Pharmacol Physiol 43:1013\u20131016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1608_CR51","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02629-16","volume":"61","author":"SY Jun","year":"2017","unstructured":"Jun SY, Jang IJ, Yoon S, Jang K, Yu KS, Cho JY, Seong MW, Jung GM, Yoon SJ, Kang SH (2017) Pharmacokinetics and tolerance of the phage endolysin-based candidate drug SAL200 after a single intravenous administration among healthy volunteers. Antimicrob Agents Chemother 61:e02629\u201316","journal-title":"Antimicrob Agents Chemother"},{"key":"1608_CR52","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/v13040680","volume":"13","author":"E Murray","year":"2021","unstructured":"Murray E, Draper LA, Ross RP, Hill C (2021) The advantages and challenges of using endolysins in a clinical setting. Viruses 13:680","journal-title":"Viruses"},{"key":"1608_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1385261","volume":"15","author":"FM Khan","year":"2024","unstructured":"Khan FM, Rasheed F, Yang Y, Liu B, Zhang R (2024) Endolysins: a new antimicrobial agent against antimicrobial resistance. Strategies and opportunities in overcoming the challenges of endolysins against Gram-negative bacteria. Front Pharmacol 15:1385261","journal-title":"Front Pharmacol"},{"key":"1608_CR54","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1128\/AAC.49.11.4789-4792.2005","volume":"49","author":"JM Entenza","year":"2005","unstructured":"Entenza JM, Loeffler JM, Grandgirard D, Fischetti VA, Moreillon P (2005) Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrob Agents Chemother 49:4789\u20134792","journal-title":"Antimicrob Agents Chemother"},{"key":"1608_CR55","doi-asserted-by":"publisher","first-page":"6276","DOI":"10.1128\/AAC.01701-13","volume":"57","author":"F Oechslin","year":"2013","unstructured":"Oechslin F, Daraspe J, Giddey M, Moreillon P, Resch G (2013) In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia. Antimicrob Agents Chemother 57:6276\u20136283","journal-title":"Antimicrob Agents Chemother"},{"key":"1608_CR56","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","volume":"34","author":"A Wright","year":"2009","unstructured":"Wright A, Hawkins CH, Anggard EE, Harper DR (2009) A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol 34:349\u2013357","journal-title":"Clin Otolaryngol"}],"container-title":["Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-025-01608-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13567-025-01608-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-025-01608-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:26:13Z","timestamp":1756902373000},"score":1,"resource":{"primary":{"URL":"https:\/\/veterinaryresearch.biomedcentral.com\/articles\/10.1186\/s13567-025-01608-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1186\/s13567-025-01608-7","relation":{},"ISSN":["1297-9716"],"issn-type":[{"value":"1297-9716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of the Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences (Approval No. HVRI-IACUC-23121901GR) and were performed according to the Animal Welfare Agency Guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}